Source : MedTech Dive

As the global medtech landscape continues to evolve, four key developments are set to shape industry priorities in the latter half of 2025. MedTech Dive’s latest analysis highlights renewed momentum in M&A activity, the growing adoption of renal denervation therapies, ongoing FDA user-fee negotiations (MDUFA), and the competitive advances in robotic surgery led by Medtronic’s Hugo system.

These trends signal how innovation, regulation, and investment are redefining healthcare globally — with strong implications for Asia’s medtech and manufacturing ecosystem.